nimbex forte injection 150 mg30 ml
dch auriga singapore - cisatracurium (bis-cation) (as besylate) 201.0 mg/30 ml eqv cisatracurium - injection, solution - 150 mg/30 ml - cisatracurium (bis-cation) (as besylate) 201.0 mg/30 ml eqv cisatracurium 150 mg/30 ml
nimbex injection 2 mgml
dch auriga singapore - cisatracurium (bis-cation) (as besylate) 2.68 mg/ml eqv cisatracurium - injection, solution - 2 mg/ml - cisatracurium (bis-cation) (as besylate) 2.68 mg/ml eqv cisatracurium 2 mg/ml
bridion solution for injection 100mgml
msd pharma (singapore) pte. ltd. - sugammadex sodium 108.8mg eqv sugammadex - injection, solution - 100mg - sugammadex sodium 108.8mg eqv sugammadex 100mg
nimbex 2mg/ml solution for injection
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - cisatracurium - solution for injection - cisatracurium 2 mg/ml - muscle relaxants
cisatracurium omega single dose solution
omega laboratories limited - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents
cisatracurium omega multidose solution
omega laboratories limited - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents
nimbex liquid
abbvie corporation - cisatracurium (cisatracurium besylate) - liquid - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents
cisatracurium besylate injection solution
mylan pharmaceuticals ulc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents
cisatracurium besylate injection (preservative-free) solution
mylan pharmaceuticals ulc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents
aj-cisatracurium solution
agila jamp canada inc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents